EP0218300 - Brain-specific drug delivery [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 18.04.1995 Database last updated on 02.09.2024 | Most recent event Tooltip | 07.07.2007 | Change - inventor | published on 08.08.2007 [2007/32] | Applicant(s) | For all designated states University of Florida P.O. Box 115500 Gainesville Florida 32611-5500 / US | [N/P] |
Former [1987/16] | For all designated states UNIVERSITY OF FLORIDA 207 Tigert Hall Gainesville, Florida 32611 / US | Inventor(s) | 01 /
Bodor, Nicholas S. 7211 South West 97th Lane Gainesville Florida 32608 / US | [1987/16] | Representative(s) | Pendlebury, Anthony, et al PAGE, WHITE & FARRER 54 Doughty Street London WC1N 2LS / GB | [1987/16] | Application number, filing date | 86201710.0 | 12.05.1983 | [1987/16] | Priority number, date | US19820379316 | 18.05.1982 Original published format: US 379316 | US19830461543 | 27.01.1983 Original published format: US 461543 | US19830475493 | 15.03.1983 Original published format: US 475493 | [1987/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0218300 | Date: | 15.04.1987 | Language: | EN | [1987/16] | Type: | A3 Search report | No.: | EP0218300 | Date: | 28.09.1988 | Language: | EN | [1988/39] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.08.1988 | Classification | IPC: | C07D215/54, C07D401/12, C07D417/12, C07D401/14, C07J43/00, A61K47/00 | [1987/16] | CPC: |
C07D213/80 (EP);
A61K47/559 (EP);
C07D209/32 (EP);
C07D211/90 (EP);
C07D213/82 (EP);
C07D401/12 (EP);
| Designated contracting states | AT, BE, CH, DE, FR, GB, LI, LU, NL, SE [1987/16] | Title | German: | Gehirnspezifische Arzneimittelabgabe | [1987/16] | English: | Brain-specific drug delivery | [1987/16] | French: | Administration d'un médicament à action spécifique sur le cerveau | [1987/16] | Examination procedure | 20.03.1989 | Examination requested [1989/21] | 27.07.1992 | Despatch of a communication from the examining division (Time limit: M10) | 12.05.1993 | Reply to a communication from the examining division | 08.07.1993 | Despatch of a communication from the examining division (Time limit: M10) | 07.04.1994 | Reply to a communication from the examining division | 01.12.1994 | Application deemed to be withdrawn, date of legal effect [1995/23] | 10.01.1995 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [1995/23] | Parent application(s) Tooltip | EP83902034.4 / EP0110955 | Fees paid | Renewal fee | 03.10.1986 | Renewal fee patent year 03 | 03.10.1986 | Renewal fee patent year 04 | 19.03.1987 | Renewal fee patent year 05 | 21.03.1988 | Renewal fee patent year 06 | 19.04.1989 | Renewal fee patent year 07 | 15.05.1990 | Renewal fee patent year 08 | 17.05.1991 | Renewal fee patent year 09 | 11.05.1992 | Renewal fee patent year 10 | 26.05.1993 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 31.05.1994 | 12   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Licence(s) | ID: | 01 00/exclusive | For: | AT BE CH DE FR GB LI LU NL SE | Licencee: | Pharmatec, Inc. P.O. Box 730 Alachua Florida 32615 / US | Date: | 28.07.1989 |
Former [1989/37] | ID: | 01 00/exclusive | |
For: | all designated states | ||
Licencee: | Pharmatec, Inc. P.O. Box 730 Alachua Florida 32615 / US | ||
Date: | Documents cited: | Search | [X] - SCIENCE, vol. 214, no. 4527, 18th December 1981; N. BODOR et al.: "Site-Specific, Sustained Release of Drugs to the Brain" | [X] - JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 67, no. 5, May 1978, pages 685-687, Washington, D.C., US; N. BODOR et al.: "Elimination of a quaternary pyridinium salt, delivered as its dihydropyridine derivative from brain of mice" | [X] - CHEMICAL AND ENGINEERING NEWS, 21st December 1981, pages 24,25, Washington, D.C., US; R. RAWLS: "New methods let drugs past blood-brain barrier" | [X] - "Drug delivery systems", Ed. R.L. JULIANO, 1980, pages 112-176, Oxford University Press; V. STELLA et al. | [X] - "Design of Biopharmaceutical Properties through Prodrugs and Analogs", Ed. B. ROCHE (editor), Am. Pharm. Assoc. 1977, pages 98-135 | [AP] - JOURNAL OF MEDICINAL CHEMISTRY, vol. 26, April 1983, pages 313-317, Columbus, Ohio, US; N. BODOR et al.: "Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenekylamine" | [AP] - JOURNAL OF MEDICINAL CHEMISTRY, vol. 26, April 1983, pages 528-534, Columbus, Ohio, US; N. BODOR et al.: "Improved delivery through biological membranes. 13. Brain specific delivery of dopamine with a dihydropyridine pyridinium salt type redox delivery system" |